Prenetics Global Limited (PRE) Stock Price & Analysis
Prenetics Global Limited (PRE) closed at USD 17.35 on Friday, October 23, 2026, up 4.71% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 16.57; the Oct 23, 2026 session ranged USD 16.81–17.85 on volume of 160,568 shares. Market capitalization is $338.57M, with a 52-week range of USD 11.37–27.24 (NGM). Source: Nexqual, retrieved October 25, 2026 at 01:53 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PRE.md
Key facts (PRE)
- Insider open-market purchases, last ~7 months: 2 Form 4 filings, $1000K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (6 analysts), mean target USD 38.13 (range 30–54).
- Total return with dividends: 1Y +3.5% vs S&P 500 +13.4%; 5Y -84.9% vs S&P 500 +76.9%.
- Next earnings: 2026-11-10, EPS estimate USD -1, revenue estimate $63.1M.
Insider purchases (SEC Form 4, open-market, last ~7 months) (PRE)
2 purchases, $1000K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-24…2026-08-25 | Rosin Brian J | CFO of IM8 (US) LLC | 23,100 | $498K | 21.55 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-20…2026-08-24 | Yeung Danny Sheng Wu | Chief Executive Officer | 24,681 | $502K | 20.34 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (PRE)
Consensus Buy (mean 2.00 on a 1–5 scale), 6 analysts; mean target USD 38.13 (low 30, high 54).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Lucid Capital Markets | Initiated | Buy | $54 |
| 2026-09-17 | Craig-Hallum | Initiated | Buy | $40 |
| 2026-08-27 | B. Riley Securities | Initiated | Buy | $37 |
| 2026-07-15 | Benchmark | Target raised | Buy | $30 → $40 |
Total return (dividends reinvested) (PRE)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +3.5% | -84.9% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +3.5% | -31.5% |
| Volatility (annualized) | 85.2% | 75.3% |
| Max drawdown | -36.9% (Aug 2026→Oct 2026) | -97.6% (May 2022→Apr 2024) |
PRE suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Alphabet (Google) (GOOGL) | “We utilize digital advertising (Google, Meta), influencer marketing, affiliate partnerships, and collaborations with healthcare providers and research institutions.” |
| Supplier | Meta Platforms (META) | “We utilize digital advertising (Google, Meta), influencer marketing, affiliate partnerships, and collaborations with healthcare providers and research institutions.” |
| Supplier | Europa Partners Holdings | “With the divestiture of our Europa 3PL business completed in January 2026 and our strategic focus now centered on IM8, we expect our gross margin profile to improve to over 60% in 2026, subject to our ability to manage input costs, optimize our supply chain, and negotiate favorable terms with contract manufacturers and logistics providers.” |
| Customer | Stord Fulfillment | “Pursuant to the APA, we sold substantially all of the assets of our Europa third-party logistics ("3PL") business, including inventory, assigned contracts (customer, vendor, warehouse and equipment lease agreements), intellectual property assets and tangible personal property, to Stord Fulfillment, LLC.” |
| Partner | Insighta Holdings | “On June 26, 2023, we entered into definitive transaction documents to establish a joint venture between Prenetics, Professor Dennis Lo, and others, namely Insighta, on June 25, 2023.” |
| Partner | MZHCI | “On April 25, 2024, we entered into an investor relations consulting agreement with MZHCI, LLC ("MZHCI"), a MZ Group company, pursuant to which MZHCI provides investor relations, investment awareness, financial media relations and public market advisory services to the Company.” |
| Partner | Europa Sports Partners | “On January 1, 2026, we entered into an Asset Purchase Agreement with an independent buyer pursuant to which we divested substantially all of the assets of the logistics, fulfillment, warehousing and distribution business operated under Europa Sports Partners, LLC.” |
| Partner | Dennis Lo and AC-Tech Investment | “In connection with the Insighta Share Sale Agreement, we entered into a Registration Rights Agreement with Professor Dennis Lo and AC-Tech Investment Limited on July 20, 2023, pursuant to which, among other things, the Company agreed to undertake certain resale shelf registration obligations in accordance with the Securities Act and granted Professor Dennis Lo and AC-Tech Investment Limited customary demand and pi…” |
| Partner | Tencent | “On October 14, 2024, Prenetics entered into a Share Purchase Agreement with Image Frame Investment (HK) Limited ("Image Frame"), an affiliate of Tencent Holdings Limited.” |
Quoted from the company's 20-F filed Apr 30, 2026.
PRE analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-1.00 | $-0.42 | +138.7% | $63.1M | 4 |
| Next quarter (ends Dec 2026) | $-1.02 | $-0.32 | +220.3% | $78.6M | 4 |
| Current fiscal year (ends Dec 2026) | $-3.54 | $-2.59 | +36.7% | $224.2M | 3 |
| Next fiscal year (ends Dec 2027) | $-2.39 | $-0.68 | +251.5% | $404.5M | 4 |
PRE options: expected move
Options price a move of about ±22.2% (±$3.85) by Nov 20, 2026, which includes earnings on Nov 10, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 27 | 97.9% | ±22.2% |
| Feb 19, 2027 | 118 | 101.5% | ±45.4% |
| May 21, 2027 | 209 | 87.1% | ±50.7% |
| Aug 20, 2027 | 300 | 90.7% | ±62.0% |
30-day implied volatility 79.8% vs 73.5% realized over the last 30 trading days. Put/call ratio (volume) —. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 25, 2026 at 01:53 UTC)
| Price | USD 17.35 |
|---|---|
| Change | ▲ 4.71% (up) |
| Previous Close | USD 16.57 |
| Open | USD 16.82 |
| Day Range | USD 16.81 – 17.85 |
| 52-Week Range | USD 11.37 – 27.24 |
| Volume | 160,568 shares |
| Market Cap | $338.57M |
| Exchange | NGM |
Technical Analysis (PRE)
Nexqual's technical model rates PRE "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 25, 2026 at 01:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.01 (neutral) |
| vs SMA50 | Below (USD 22.13) |
| MACD | -1.39 (negative) |
Analyst Ratings (PRE)
Wall Street analysts rate PRE "Buy" based on 6 analysts, with a mean price target of USD 38.13 (range USD 30–54), per Nexqual as of October 25, 2026 at 01:53 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 38.13 |
| High Target | USD 54 |
| Low Target | USD 30 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (PRE)
| Next Earnings Date | 2026-11-10 |
|---|---|
| EPS Estimate | USD -1 |
| Revenue Estimate | $63.13M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.52 vs est -0.48 ▼ miss |
| 2026-03-31 | USD -1.36 vs est -0.78 ▼ miss |
| 2025-12-31 | USD -0.19 vs est -0.52 ▲ beat |
| 2025-09-30 | USD -0.53 vs est -0.55 ▲ beat |
Source: Nexqual, October 25, 2026 at 01:53 UTC.
Financials & Fundamentals (PRE)
| Total Revenue | $154.59M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +210.70% |
| Gross Margin | +57.77% |
| Operating Margin | -45.13% |
| Profit Margin | -30.40% |
| ROE | -47.01% |
| Debt / Equity | 0.01 |
| Current Ratio | 4.04 |
| Total Cash | $128.56M |
| Total Debt | $682,000 |
Source: Nexqual, October 25, 2026 at 01:53 UTC.
Financial Health Score (PRE)
Nexqual rates Prenetics Global Limited's overall financial health "Mixed" across five dimensions, as of October 25, 2026 at 01:53 UTC.
| Growth | Strong — Revenue +202% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 58%, operating -45% (last 12 months) |
| Balance Sheet | Strong — $129M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$40M (TTM) |
| Efficiency | Critical — ROE -47%, ROA -18.9% |
Ownership (PRE)
| Insider Ownership | +14.55% |
|---|---|
| Institutional Ownership | +7.92% |
| Shares Outstanding | 17.93M |
| Float | 12.78M |
| Short % of Float | +2.59% |
Source: Nexqual, October 25, 2026 at 01:53 UTC.
Leadership (PRE)
Prenetics Global Limited is led by Sheng Wu Yeung, Co-Founder, Chairperson & CEO, per Nexqual as of October 25, 2026 at 01:53 UTC.
| Co-Founder, Chairperson & CEO | Sheng Wu Yeung |
|---|---|
| Chief Financial Officer of U.S. | Brian J. Rosin |
Major Backers & Investors (PRE)
Notable institutional backers of Prenetics Global Limited include Prospect Capital Advisors, LLC, Jane Street Group, LLC, Goldman Sachs, according to Nexqual as of October 25, 2026 at 01:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Prospect Capital Advisors, LLC | 1.54% |
| Jane Street Group, LLC | 1.47% |
| Goldman Sachs | 1.1% |
| Millennium Management | 0.82% |
| Tenzing Global Management, Llc | 0.82% |
| Marshall Wace LLP | 0.31% |
| Nomura Holdings Inc. | 0.28% |
| Susquehanna International Group, LLP | 0.25% |
Source: Nexqual, October 25, 2026 at 01:53 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INGR | Ingredion Incorporated | USD 95.7 | ▼ 1.52% |
| CPB | The Campbell's Company | USD 20.73 | ▼ 2.49% |
| PPC | Pilgrim's Pride Corporation | USD 28.13 | ▲ 0.14% |
| CAG | ConAgra Brands, Inc. | USD 14.86 | ▼ 1.39% |
| SFD | Smithfield Foods, Inc. | USD 18.64 | ▼ 0.93% |
| LW | Lamb Weston Holdings, Inc. | USD 53.83 | ▼ 2.45% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 25, 2026 at 01:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt